Padres place a high-stakes bet on Michael King with a three-year, $75 million pact that also includes opt-out rights after the 2026 and 2027 seasons. And this is the part that sparks both curiosity and debate: the deal gives King real leverage to re-enter free agency if he performs and stays healthy, while San Diego secures a controlled window to evaluate his upside.
According to reports shared by ESPN’s Jeff Passan, the San Diego Padres and the right-hander agreed to the three-year contract, which features opt-out opportunities following the 2026 and 2027 campaigns. The arrangement signals the team’s belief that King can bounce back and deliver more of the effectiveness he showed earlier in his San Diego tenure.
King’s 2025 season was disrupted by injuries, limiting him to just 15 starts. He spent significant time sidelined by a knee issue and a nerve problem in his right shoulder. When he did pitch, he went 5-3 with a 3.44 ERA and struck out 76 batters over 73 1/3 innings.
At age 30, King’s repertoire relies on a sinker and a changeup, with the four-seam fastball playing a secondary role. That mix yielded strong results in his 2024 introduction to San Diego, when he produced a 3.9 WAR and a 2.95 ERA across 173 2/3 innings in 30 starts, a season that earned him seventh place in National League Cy Young voting.
What changed in 2025 wasn’t the overall stuff so much as how opponents tracked his four-seamer. The performance on that pitch deteriorated, with a sharp rise in hard contact — slugging allowed on the four-seam accelerated from .402 in 2024 to .814 in 2025 — contributing to the tougher outcomes that season.
The Padres also made the familiar move of extending a qualifying offer, presenting King with a $22.025 million offer after the 2024 season, which he declined by the November 18 deadline.
King’s career before joining San Diego included five years with the New York Yankees, where he posted a 31-29 record, a 3.24 ERA, and 559 strikeouts.
MLB.com was the first to report the latest development.
Now the question many fans and analysts are weighing: is this a savvy bet on potential value, given the injury history and the opt-out flexibility, or a calculated risk that could backfire if durability remains an issue? How would you assess the balance between upside and health risk in a deal like this?
